Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extramammary Paget Disease: A Single-Center, Clinical Analysis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Rural-urban disparities in melanoma management: A SEER database analysis of wide local excision vs Mohs surgery utilization and disease-specific outcomes.

Journal of the American Academy of Dermatology·2026
Same author

Patient Satisfaction With Outcomes of Mohs Micrographic Surgery: A Prospective Cohort Study Using the Oxford Skin Cancer Treatment Scale.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Treatment-Based Outcomes Analysis for Dermatofibrosarcoma Protuberans: A Single-Center Study.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025
Same author

High-Stage Cutaneous Squamous Cell Carcinoma in a Pregnant Patient.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025
Same author

Medical Spa Legislation, Regulations, and Guidelines in the United States.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025

Related Experiment Video

Updated: Jun 14, 2025

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

845

Tranexamic Acid in Mohs Micrographic Surgery: A Systematic Review.

Eenika A Kumar1, Lisa M Morris2, Basia M Michalski-McNeely2

  • 1University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|September 5, 2024
PubMed
Summary

Tranexamic acid (TXA) shows promise for hemostasis in Mohs surgery. This antifibrinolytic agent offers a safe and effective alternative to traditional methods, potentially improving patient outcomes and reducing bleeding.

More Related Videos

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

891
Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus
07:24

Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus

Published on: January 23, 2018

10.3K

Related Experiment Videos

Last Updated: Jun 14, 2025

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

845
Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

891
Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus
07:24

Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus

Published on: January 23, 2018

10.3K

Area of Science:

  • Dermatology
  • Surgical Oncology
  • Pharmacology

Background:

  • Tranexamic acid (TXA) is an established antifibrinolytic agent.
  • Historically used for menorrhagia and bleeding disorders.
  • Emerging applications in surgical procedures for hemostasis with a favorable safety profile.

Conclusions:

  • Tranexamic acid (TXA) shows significant potential for improving patient outcomes in Mohs micrographic surgery (MMS).
  • TXA may reduce surgical time and intraoperative/postoperative bleeding.
  • Increased patient satisfaction is a potential benefit of using TXA.